Symbol="NBSE"
AssetType="Common Stock"
Name="NeuBase Therapeutics Inc"
Description="NeuBase Therapeutics, Inc., a preclinical biopharmaceutical company, focuses on developing therapies to treat rare genetic diseases and cancers caused by mutant genes. The company is headquartered in Pittsburgh, Pennsylvania."
CIK="1173281"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="800 THIRD AVENUE, 11TH FLOOR, NEW YORK, NY, US"
FiscalYearEnd="September"
LatestQuarter="2023-03-31"
MarketCapitalization="3155300"
EBITDA="-23408468"
PERatio="None"
PEGRatio="None"
BookValue="8.55"
DividendPerShare="0"
DividendYield="0"
EPS="-17.91"
RevenuePerShareTTM="0"
ProfitMargin="0"
OperatingMarginTTM="0"
ReturnOnAssetsTTM="-0.43"
ReturnOnEquityTTM="-0.935"
RevenueTTM="0"
GrossProfitTTM="0"
DilutedEPSTTM="-17.91"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0"
AnalystTargetPrice="140"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="-"
PriceToBookRatio="0.224"
EVToRevenue="-"
EVToEBITDA="0.524"
Beta="0.65"
num_52WeekHigh="29"
num_52WeekLow="1.68"
num_50DayMovingAverage="3.182"
num_200DayMovingAverage="4.301"
SharesOutstanding="1690500"
DividendDate="2019-02-04"
ExDividendDate="None"
symbol="NBSE"
open="1.85"
high="1.87"
low="1.68"
price="1.68"
volume="56578.00"
latest_trading_day="2023-07-07"
previous_close="1.81"
change="-0.13"
change_percent="-7.1823%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="74"
trend_strength="Absent or Weak Trend"
buying_signal="Strong Sell Signal"
volume_analysis="Trending High"
value_analysis="Bullish Trend"
Aroon_change="FALSE"
Aroon_momentum="26"
Volume_recent_avg="397421"
Change_recent_avg="-0.02"
Delta_recent_avg="0.09"
Variance_recent_avg="0.04"
Change_ratio_recent_avg="-1.43"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="26"
Aroon_momentum_negative="74"
image_negative_thumbnail_id_1="166"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0010.jpeg"
image_negative_thumbnail_id_2="1099"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0132.jpeg"
image_neutral_thumbnail_id_1="579"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0020.jpeg"
image_neutral_thumbnail_id_2="566"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0033.jpeg"
image_positive_thumbnail_id_1="993"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0155.jpeg"
image_positive_thumbnail_id_2="992"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0154.jpeg"
image_professor_thumbnail_id_1="1190"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0024.jpeg"
image_professor_thumbnail_id_2="1201"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0035.jpeg"
